PL1664315T3 - Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów - Google Patents
Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawówInfo
- Publication number
- PL1664315T3 PL1664315T3 PL04774913T PL04774913T PL1664315T3 PL 1664315 T3 PL1664315 T3 PL 1664315T3 PL 04774913 T PL04774913 T PL 04774913T PL 04774913 T PL04774913 T PL 04774913T PL 1664315 T3 PL1664315 T3 PL 1664315T3
- Authority
- PL
- Poland
- Prior art keywords
- gene therapy
- vivo gene
- rheumatoid arthritis
- aav vectors
- virions
- Prior art date
Links
- 238000001415 gene therapy Methods 0.000 title abstract 4
- 238000001727 in vivo Methods 0.000 title abstract 3
- 206010039073 rheumatoid arthritis Diseases 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 210000002845 virion Anatomy 0.000 abstract 2
- 241000702421 Dependoparvovirus Species 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL0300611 | 2003-09-01 | ||
| EP04774913A EP1664315B1 (en) | 2003-09-01 | 2004-09-01 | Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| PCT/NL2004/000607 WO2005021768A1 (en) | 2003-09-01 | 2004-09-01 | Aav vectors for in vivo gene therapy of rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1664315T3 true PL1664315T3 (pl) | 2012-09-28 |
Family
ID=34270790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04774913T PL1664315T3 (pl) | 2003-09-01 | 2004-09-01 | Wektory aav do terapii genowej in vivo reumatoidalnego zapalenia stawów |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP2322638A1 (pl) |
| JP (1) | JP4863874B2 (pl) |
| AT (1) | ATE556140T1 (pl) |
| AU (1) | AU2004269279B2 (pl) |
| CA (1) | CA2536471C (pl) |
| DK (1) | DK1664315T3 (pl) |
| ES (1) | ES2384975T3 (pl) |
| PL (1) | PL1664315T3 (pl) |
| PT (1) | PT1664315E (pl) |
| WO (1) | WO2005021768A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009534394A (ja) * | 2006-04-21 | 2009-09-24 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 結合組織障害の治療 |
| MX381665B (es) | 2016-01-13 | 2025-03-13 | Genzyme Corp Star | Vectores aav recombinantes que expresan genes osteoprotectores, que incluyen has2 y lubricina, de utilidad en el tratamiento de la osteoartritis y afecciones articulares relacionadas en mamiferos. |
| JP7389040B2 (ja) * | 2018-01-17 | 2023-11-29 | メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド | 遺伝子治療のための修飾rAAVキャプシドタンパク質 |
| WO2020150633A1 (en) * | 2019-01-18 | 2020-07-23 | Orthobio Therapeutics, Inc. | Gene editing to improve joint function |
| US20250213727A1 (en) | 2022-03-25 | 2025-07-03 | Regenxbio Inc. | Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy |
| IL319433A (en) * | 2022-09-07 | 2025-05-01 | Remedium Bio Inc | Osteoarthritis treatment |
| CN116983432A (zh) * | 2023-07-07 | 2023-11-03 | 深圳先进技术研究院 | 用于治疗类风湿性关节炎的药物 |
| CN122161846A (zh) * | 2023-10-11 | 2026-06-05 | 四川至善唯新生物科技有限公司 | 治疗关节炎的组合物和方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| US5952221A (en) | 1996-03-06 | 1999-09-14 | Avigen, Inc. | Adeno-associated virus vectors comprising a first and second nucleic acid sequence |
| US6046319A (en) | 1997-10-22 | 2000-04-04 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of TNF-α |
| DE69939169D1 (de) | 1998-05-28 | 2008-09-04 | Us Gov Health & Human Serv | Aav5 vektoren und deren verwendung |
| US6537540B1 (en) * | 1999-05-28 | 2003-03-25 | Targeted Genetics Corporation | Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| US6596535B1 (en) * | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| US20040191221A1 (en) * | 2001-05-22 | 2004-09-30 | Keiya Ozawa | Methods of treating skeletal disorders using recombinant adeno-associated virus virions |
| US20030003583A1 (en) * | 2001-06-08 | 2003-01-02 | Raphael Hirsch | Regulation of transgene expression following AAV transduction |
| US20040072351A1 (en) * | 2002-04-30 | 2004-04-15 | Womer Karl L. | Methods and compositions for expressing a nucleic acid in a dendritic cell |
-
2004
- 2004-09-01 WO PCT/NL2004/000607 patent/WO2005021768A1/en not_active Ceased
- 2004-09-01 EP EP10175639A patent/EP2322638A1/en not_active Withdrawn
- 2004-09-01 CA CA2536471A patent/CA2536471C/en not_active Expired - Lifetime
- 2004-09-01 JP JP2006525289A patent/JP4863874B2/ja not_active Expired - Lifetime
- 2004-09-01 PT PT04774913T patent/PT1664315E/pt unknown
- 2004-09-01 AT AT04774913T patent/ATE556140T1/de active
- 2004-09-01 EP EP04774913A patent/EP1664315B1/en not_active Expired - Lifetime
- 2004-09-01 AU AU2004269279A patent/AU2004269279B2/en not_active Expired
- 2004-09-01 DK DK04774913.0T patent/DK1664315T3/da active
- 2004-09-01 PL PL04774913T patent/PL1664315T3/pl unknown
- 2004-09-01 ES ES04774913T patent/ES2384975T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004269279B2 (en) | 2010-02-25 |
| EP1664315B1 (en) | 2012-05-02 |
| JP2007504219A (ja) | 2007-03-01 |
| CA2536471C (en) | 2013-10-08 |
| AU2004269279A1 (en) | 2005-03-10 |
| ATE556140T1 (de) | 2012-05-15 |
| PT1664315E (pt) | 2012-07-31 |
| DK1664315T3 (da) | 2012-07-09 |
| WO2005021768A1 (en) | 2005-03-10 |
| EP2322638A1 (en) | 2011-05-18 |
| ES2384975T3 (es) | 2012-07-16 |
| JP4863874B2 (ja) | 2012-01-25 |
| EP1664315A1 (en) | 2006-06-07 |
| CA2536471A1 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1496944T1 (sl) | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov | |
| DE69929600D1 (de) | Konvektion-erhöhte verabreichung aadc-kodierende aav vektoren | |
| MXPA03010079A (es) | Formulaciones de oxicodona de administracion una vez al dia. | |
| WO2007130455A3 (en) | Compositions and methods for treatment of non-hodgkins lymphoma | |
| MXPA05013526A (es) | Secuencias de acido nucleico que codifican y composiciones que comprenden el peptido de senal de ige y/o il-15 y metodos para uso de los mismos. | |
| EP1546343A4 (en) | PRODUCTION OF RECOMBINANT AAV HIGH TITER | |
| DK1664315T3 (da) | AAV-vektorer til in vivo genterapi af rheumatoid arthritis | |
| WO2002102316A3 (en) | Histone deacetylase and methods of use thereof | |
| NZ334839A (en) | Polynucleotide molecules encoding neospora proteins and uses thereof | |
| MXPA04004561A (es) | Distribuidor de aire para sistema de biolixiviacion. | |
| WO2002008257A3 (en) | Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof | |
| ATE480620T1 (de) | Neue pgc-1-isoformen und deren verwendungen | |
| WO2004087886A3 (en) | Modified adenoviral e1a constructs and methods of use thereof | |
| WO2002070657A3 (en) | 93870, a human g-protein coupled receptor and uses therefor | |
| WO2002016591A3 (en) | Human transporter family members and uses thereof | |
| IL174645A0 (en) | MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES | |
| WO2002016578A3 (en) | Secreted proteins and methods of using same | |
| ATE445714T1 (de) | 15603, ein mitglied der humanen ionenkanal- familie | |
| WO2004013281A3 (en) | Novel proteins and their uses | |
| ATE476194T1 (de) | Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür | |
| WO2004044126A3 (en) | Novel proteins and their uses | |
| WO2002077190A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| WO2003074675A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
| WO2003008621A3 (en) | 87144, human amino acid transporter family member and uses therefor | |
| WO2003031463A3 (en) | 14081, a human trypsin-like serine protease family member and uses therefor |